Laboratory monitoring of haemostasis

Anaesthesia

Volumn 70, Issue S1, 2015, Pages 68-72

  Fowler, A ^a   Perry, D J ^a  

^a CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING TEST; HEMOSTASIS; HUMAN; PATIENT MONITORING; PREOPERATIVE CARE;

BLOOD COAGULATION TESTS; HEMOSTASIS; HUMANS; MONITORING, INTRAOPERATIVE; PREOPERATIVE CARE;

EID: 84925221933     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/ANAE.12919     Document Type: Review

References (12)

1. Blumberg N. Deleterious clinical effects of transfusion immu-nomodulation: proven beyond a reasonable doubt. Transfusion 2005; 45: S33–9.
2. Chee YL, Crawford JC, Watson H, Greaves M. Guidelines on the assessment of bleeding risk prior to surgery or invasive proce-dures. British Journal of Haematology 2008; 140: 496–504.
3. NICE. Preoperative tests: The use of routine preoperative tests for elective surgery, 2003. http://www.nice.org.uk/guidance/cg3(accessed 18/09/2014).
4. Kozek-Langenecker SA. Perioperative coagulation monitoring. Best Practice and Research Clinical Anaesthesiology 2010; 24: 27–40.
5. Broomhead RH, Mallett SV. Clinical aspects of coagulation. Anaesthesia and Intensive Care Medicine 2010; 11: 195–9.
6. Versteeg HH, Heemskert JWM, Levi M, Reitsma PH. New fun-damentals in hemostasis. Physiology Reviews 2011; 93: 327– 58.
7. Harrison P, Mackie I, Mumford A, et al. Guidelines for the laboratory investigation of heritable disorders of platelet func-tion. British Journal of Haematology 2011; 155: 30–44.
8. Mackie IJ, Kitchen S, Machin SJ, Lowe GD. Guidelines on fibrin-ogen assays. British Journal of Haematology 2003; 121: 396– 404.
9. Hardy JF, de Moerloose P, Samama CM. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Canadian Journal of Anesthesia 2006; 53: S40–58.
10. Hiippala ST. Dextran and hydroxyethyl starch interfere with fibrinogen assays. Blood Coagulation and Fibrinolysis 1995; 6: 743–6.
11. Ciavarella D, Reed RL, Counts RB, et al. Clotting factor levels and the risk of diffuse microvascular bleeding in the mas-sively transfused patient. British Journal of Haematology 1987; 67: 365–8.
12. Segal JB, Dzik WH. Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence-based review. Transfusion 2005; 45: 1413–25.